Table 1. Immunohistochemical results in 13 MELTVR patients reported thus far.
| Author (References) |
Immunohistochemistry findings | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PgR | ER | EMA | GFAP | S100 | CD34 | INI1 | AE1/AE3 | SMA | Desmin | |
| Yoshida et al.1) (n = 9) | + | + | + | – | – | – | – | + | + | NA |
| Kaku et al.4) (n = 1) | + | + | + | – | – | – | – | + | – | NA |
| Kojima et al.5) (n = 1) | NA | + | + | – | – | – | – | – | + | – |
| Xu et al.6) (n = 1) | NA | + | + | – | – | – | – | – | – | – |
| Our case (n = 1) | + | + | + | – | – | – | – | – | + | – |
EMA, epithelial membrane antigen; ER, estrogen receptor; GFAP, glial fibrillary acidic protein; MELTVR, myoepithelioma-like tumor of the vulvar region; NA, not available; PgR, progesterone receptor